COVID-19

• EMA

• COVID-19- chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes 01.04.2020

• Update on treatments and vaccines against COVID-19 under development 31.03.2020

• EMA kılavuz güncellemesi 30 nisan 2*020

• COVID-19- chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes 01.04.2020

• Update on treatments and vaccines against COVID-19 under development 31.03.2020

• EMA kılavuz güncellemesi 30 nisan 2*020

• FDA

• Coronavirus Treatment Acceleration Program (CTAP) | FDA 02.04.2020

• FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic 20.03.2020

• Investigational COVID-19 Convalescent Plasma - Emergency INDs FDA 24.03.2020

• Emergency Use Authorization of Medical Products and Related Authorities 01.2017

• Updated FDA Guideline 16 April 2020

• COVID 19: Developing Drugs and Biological Products for Treatment or Prevention Guidance for Industry May 2020

• Development and Licensure of Vaccines to Prevent COVID-19 June 2020

• Coronavirus Treatment Acceleration Program (CTAP) | FDA 02.04.2020

• FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic 20.03.2020

• Investigational COVID-19 Convalescent Plasma - Emergency INDs FDA 24.03.2020

• Emergency Use Authorization of Medical Products and Related Authorities 01.2017

• Updated FDA Guideline 16 April 2020

• COVID 19: Developing Drugs and Biological Products for Treatment or Prevention Guidance for Industry May 2020

• Development and Licensure of Vaccines to Prevent COVID-19 June 2020

• UNESCO

• Ethical Considerations from a global perspective 26.03.2020

• Ethical Considerations from a global perspective 26.03.2020

• WHO

• Guidance for Managing Ethical Issues in Infectious Disease Outbreaks 2016

• Guidance for Managing Ethical Issues in Infectious Disease Outbreaks 2016

• SAĞLIK BAKANLIĞI (MoH)

• COVID-19 Pandemisi Nedeniyle Klinik Araştırmalarda Alınacak Tedbirler 19.03.2020

• Immun plazma tedarik yazısı 01.04.2020

• COVID-19 araştırmaları ile ilgili SB genelgesi 16.04.2020

• Klinik Araştırmalar ile Bilimsel Araştırma ve Projeler hakkında yazı 28.04.2020

• COVID-19 Pandemisi Nedeniyle Klinik Araştırmalarda Alınacak Tedbirler V2.0

• COVID-19 Aşısında Klinik Araştırmalara Başlamak İçin Gereklilikler duyurusu

• COVID-19 Pandemisi Nedeniyle Klinik Araştırmalarda Alınacak Tedbirler 19.03.2020

• Immun plazma tedarik yazısı 01.04.2020

• COVID-19 araştırmaları ile ilgili SB genelgesi 16.04.2020

• Klinik Araştırmalar ile Bilimsel Araştırma ve Projeler hakkında yazı 28.04.2020

• COVID-19 Pandemisi Nedeniyle Klinik Araştırmalarda Alınacak Tedbirler V2.0

• COVID-19 Aşısında Klinik Araştırmalara Başlamak İçin Gereklilikler duyurusu

• HASTANELER (HOSPITALS)

• Dana Farber Direct mailing of sponsor drug 17.03.2020

• MD Anderson AuditConnect for External Research Monitors Quick Start Guide 09.03.2020

• Memorial Sloan Kettering CR Activities 16.03.2020

• Dana Farber Direct mailing of sponsor drug 17.03.2020

• MD Anderson AuditConnect for External Research Monitors Quick Start Guide 09.03.2020

• Memorial Sloan Kettering CR Activities 16.03.2020

• KILAVUZLAR (GUIDELINES)

• TransCelerate Protocol Deviation Process Guide March 2020

• ICMRA - Global regulatory workshop on COVID-19 vaccine development - March 18

• TransCelerate Protocol Deviation Process Guide March 2020

• ICMRA - Global regulatory workshop on COVID-19 vaccine development - March 18

• KAD (CLINICAL RESEARCH ASSOCIATION)

• COVID-19 İÇİN AŞI VE MOLEKÜL GELİŞTİREN ARAŞTIRMACILARIN DİKKATİNE KLİNİK ARAŞTIRMALAR DERNEĞİ DUYURUSU 3.03.2020

• COVID-19 İÇİN AŞI VE MOLEKÜL GELİŞTİREN ARAŞTIRMACILARIN DİKKATİNE KLİNİK ARAŞTIRMALAR DERNEĞİ DUYURUSU 3.03.2020

• AŞILAR (VACCINES)

• FDA Vaccine and Related Biological Product Guidances 2019

• EMA Guideline on clinical evaluation of vaccines 18.10.2006

• WHO Guidelines on clinical evaluation of vaccines-regulatory expectations 2004.pdf

• COVID-19 İÇİN AŞI VE MOLEKÜL GELİŞTİREN ARAŞTIRMACILARIN DİKKATİNE KLİNİK ARAŞTIRMALAR DERNEĞİ DUYURUSU 3.03.2020

• FDA Vaccine and Related Biological Product Guidances 2019

• EMA Guideline on clinical evaluation of vaccines 18.10.2006

• WHO Guidelines on clinical evaluation of vaccines-regulatory expectations 2004.pdf

• COVID-19 İÇİN AŞI VE MOLEKÜL GELİŞTİREN ARAŞTIRMACILARIN DİKKATİNE KLİNİK ARAŞTIRMALAR DERNEĞİ DUYURUSU 3.03.2020

• STK (NGO)

• KAD 8 Mayıs 2020

• Bilim Akademisi 12 Mayıs 2020

• Türk Toraks Derneği

• KAD 8 Mayıs 2020

• Bilim Akademisi 12 Mayıs 2020

• Türk Toraks Derneği